首页> 外文期刊>JAMA: the Journal of the American Medical Association >Abciximab vs thrombectomy for reperfusion in myocardial infarction
【24h】

Abciximab vs thrombectomy for reperfusion in myocardial infarction

机译:阿昔单抗与血栓切除术在心肌梗死中的再灌注

获取原文
获取原文并翻译 | 示例
       

摘要

To the Editor: The study by Dr Stone and colleagues investigated the effect on infarct size of a pharmacological strat-egy, a mechanical strategy, or both aimed at improving myo-cardial perfusion at the tissue level. Distal embolization is considered to play a major role in poor myocardial perfusion at the tissue level and is associated with poor angiographic results, larger infarct size, and subsequent worse clinical outcomes after primary percutaneous coronary intervention (PCI). Previous studies have shown a beneficial effect of manual thrombectomy on markers of reperfusion and infarct size. The Thrombus Aspiration during Percutaneous Coronary Intervention in Acute Myocardial Infarction study (TAPAS) showed that manual thrombectomy resulted in better myocardial blush and ST-segment resolution. However, in the INFUSE-AMI study, manual thrombectomy was not associated with an improvement in these surrogate end points and subsequent smaller infarct size.
机译:致编辑:Stone博士及其同事的研究调查了旨在改善组织水平心肌灌注的药理学策略,机械策略或两者对梗塞面积的影响。远端栓塞被认为在组织水平不良的心肌灌注中起主要作用,并与不良的血管造影结果,更大的梗塞面积以及随后的经皮冠状动脉介入治疗(PCI)后临床效果较差有关。先前的研究表明,手动血栓切除术对再灌注和梗死面积标记具有有益作用。急性心肌梗死经皮冠状动脉介入治疗期间的血栓抽吸研究表明,手动血栓切除术可改善心肌红斑和ST段的分辨率。但是,在INFUSE-AMI研究中,手动血栓切除术与这些替代终点的改善以及随后较小的梗塞面积无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号